Literature DB >> 21273120

Staphylococcus aureus ClpC is involved in protection of carbon-metabolizing enzymes from carbonylation during stationary growth phase.

Indranil Chatterjee1, Etienne Maisonneuve, Benjamin Ezraty, Mathias Herrmann, Sam Dukan.   

Abstract

The ability of Staphylococcus aureus to adapt to various conditions of stress is the result of a complex regulatory response. Among them, ClpC, belonging to the Hsp100/Clp ATPase family, seems to play an important role. For instance, we previously demonstrated that a functional clpC deletion resulted in enhanced survival in the late stationary phase (death phase period) compared to the parental S. aureus strain. However, the mechanisms for the enhanced survival of a S. aureus clpC mutant during the death phase period are still elusive. In Escherichia coli, among the factors that might lead to bacterial cell death during stationary phase, the amount of protein aggregates and/or oxidized proteins appears to be of major importance. Thus, in the present study, we have evaluated protein aggregates and carbonylated protein (as a marker of protein oxidation) contents both in the wild type and in an S. aureus clpC mutant during the exponential growth phase and the death phase. Whereas at all time points the tested clpC mutant exhibits the same amount of protein aggregates as the WT strain, the total amount of carbonylated proteins appears to be lower in the clpC mutant. Moreover, we observed that at the entrance of the death phase carbon-metabolizing enzymes [such as the TCA cycle enzymes Mqo2 (malate: quinone oxidoreductase) and FumC/CitG (fumarate hydratase)] albeit not the bulk proteins are carbonylated to a larger extent in the clpC mutant. Reduced activity of the TCA cycle due to specific carbonylation of these proteins will result in a decrease of endogenous oxidative stress which in turn might confer enhanced survival of the clpC mutant during the death phase period thus contributing to bacterial longevity and chronic infection.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21273120     DOI: 10.1016/j.ijmm.2010.10.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  6 in total

1.  The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistance.

Authors:  Ambre Jousselin; William L Kelley; Christine Barras; Daniel P Lew; Adriana Renzoni
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

2.  Staphylococcal ClpXP protease targets the cellular antioxidant system to eliminate fitness-compromised cells in stationary phase.

Authors:  Abdulelah A Alqarzaee; Sujata S Chaudhari; Mohammad Mazharul Islam; Vikas Kumar; Matthew C Zimmerman; Rajib Saha; Kenneth W Bayles; Dorte Frees; Vinai C Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

3.  The mcsB gene of the clpC operon is required for stress tolerance and virulence in Staphylococcus aureus.

Authors:  Darren J Wozniak; Kiran B Tiwari; Rami Soufan; Radheshyam K Jayaswal
Journal:  Microbiology (Reading)       Date:  2012-08-17       Impact factor: 2.777

4.  Staphylococcus aureus SufT: an essential iron-sulphur cluster assembly factor in cells experiencing a high-demand for lipoic acid.

Authors:  Ameya A Mashruwala; Christina A Roberts; Shiven Bhatt; Kerrie L May; Ronan K Carroll; Lindsey N Shaw; Jeffrey M Boyd
Journal:  Mol Microbiol       Date:  2016-10-21       Impact factor: 3.501

5.  Effects of ClpP protease on biofilm formation of Enterococcus faecalis.

Authors:  Ying Feng; Hongyuan Wang; H E Lu; Liu Yi; L I Hong
Journal:  J Appl Oral Sci       Date:  2021-03-01       Impact factor: 2.698

6.  Investigations to the Antibacterial Mechanism of Action of Kendomycin.

Authors:  Yasser A Elnakady; Indranil Chatterjee; Markus Bischoff; Manfred Rohde; Michaele Josten; Hans-Georg Sahl; Mathias Herrmann; Rolf Müller
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.